Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
Serena Veschi(University of Chieti-Pescara), Alessandro Cama(University of Chieti-Pescara)
Cited by 59
Related Papers
Effects of PPARα inhibition in head and neck paraganglioma cells
|PLoS ONE|2017|35
Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells
|Scientific Reports|2020|19